Development of a novel treatment approach to Neurofibromatosis Type 1-related MPNST using genetically engineered Clostridium novyi-NT

syn4939884

Created By Thomas Yu thomas.yu

grantDOI: https://doi.org/10.54464/pc.gr.147653
studyName: Development of a novel treatment approach to Neurofibromatosis Type 1-related MPNST using genetically engineered Clostridium novyi-NT
dataStatus: Data Not Expected
initiative: Francis S. Collins Scholars Program
studyLeads: Verena Staedtke
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1538265600000
institutions: Johns Hopkins Medical Institute
fundingAgency: NTAP
manifestation: Plexiform Neurofibroma
embargoEndDate: 1585526400000
grantStartDate: 1443657600000
relatedStudies: syn51204782 syn11638893 syn52396692 syn22267330
studyFileviewId: syn11678414
Welcome to the NTAP Novel Treatment Approach to Neurofibromatosis Type 1-related MPNST Forum
syn34271625
syn11678414

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Development of a novel treatment approach to Neurofibromatosis Type 1-related MPNST using genetically engineered Clostridium novyi-NT

syn4939884

Drop files to upload

Development of a novel treatment approach to Neurofibromatosis Type 1-related MPNST using genetically engineered Clostridium novyi-NT page is loading…